<!DOCTYPE html>

<html lang="en">
<head>
	<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
	<meta name="viewport" content="width=device-width, initial-scale=1">
	<title></title>
	<link rel="stylesheet" href="css/pd.css" type="text/css" />
	<link rel="stylesheet" href="css/animate.css" type="text/css" />
	<script type="text/javascript" src="js/base.js"></script>
	<script type="text/javascript" src="js/Common.js"></script>
    <script type="text/javascript" charset="utf-8">
		

		ANIMATION = [

		   ];
		
	</script>

</head>

<body class="slide-2">

<div id="content">
<div class="collage"></div>

<header>Study 730: Discontinuations were similiar in QD and BID arms</header>

<div class="logo"></div>

<section>

<article>

    <div class="chartbk">
     <div>*Patients and/or investigators may have provided more than one reason for discontinuation.</div>
    
    </div>
    
    <div class="chartdisc">
    <p><strong>Safety Considerations</strong></p>
    <p class="bullet">The most common adverse events of moderate-to-severe intensity in <span class="symbol">â‰¥</span>2% of subjects were diarrhea, nausea,<br>vomiting, and headache.</p>
	<p class="hyphen">&ndash; 17% and 15% of patients experienced diarrhea in the QD and BID arms, respectively. The incidence of diarrhea<br>of any severity during 48 weeks of therapy was 60% for the QD group and 57% for the BID group.</p>
    </div>

</article>
</section>

<div class="buttonwrap">
    <button onclick="makecall('PopupWithHeader',Array('pd-02-popup-01','Study Design','<table width=\'690px\'><tr align=\'center\'><td class=\'reference\'>730 Study Design<sup>2</sup></td></tr></table>','90','616','10','0','690','542','1','0','1','0'));">Study Design
    </button>
</div>

<footer>Please click buttons above for Indication and Important Safety Information about KALETRA.</footer>
5
</div>
</body>
</html>